Nct03615326 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nct03615326. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nct03615326 Today - Breaking & Trending Today

Dr Janjigian on Pembrolizumab/Trastuzumab/Chemotherapy in HER2+ Gastric Cancer

Yelena Y. Janjigian, MD, discusses results from the primary progression-free survival and interim overall survival analyses of the phase 3 KEYNOTE-811 trial in patients with HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma, and contextualizes these findings with previously reported data from this trial. ....

Yelenay Janjigian , Gastrointestinal Oncology Service , Memorial Sloan Kettering Cancer Center , Keynote 811 Trial , Patients With Her2 Positive Metastatic Gastric Or Gastroesophageal Junction Adenocarcinoma ,